DCGI permits Covaxin clinical trials on children
The Drugs Controller General of India (DCGI) on Thursday approved the clinical trials of Bharat Biotech's Covaxin on children from 2 to 18 years. Hyderabad-based Bharat Biotech in a statement said that its phase II and III trials will be conducted on 525 healthy volunteers. Reports stated that the clinical trials will consist of two doses injected on day 1 and day 28. It is the first covid vaccine in India that will be tested on children. As per the statement, the clinical trials are going to take place at AIIMS Delhi, AIIMS Patna, and Meditrina Institute of Medical Sciences in Nagpur.